Beam Therapeutics Inc. - COMMON STOCK (BEAM)

Historical Holders from Q1 2020 to Q3 2025

Symbol
BEAM on Nasdaq
CUSIP
07373V105
Type / Class
Equity / COMMON STOCK
Shares outstanding
101M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
107M
Holdings value
$2.59B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
210
Number of buys
111
Number of sells
-89
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beam Therapeutics Inc. - COMMON STOCK (BEAM)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13.6% -9.33% $334M -$32M 13.8M -8.73% FMR LLC Sep 30, 2025
ARK Investment Management LLC 10.35% +30.4% $223M $83.2M 10.4M +59.4% ARK Investment Management LLC Jul 31, 2025
Farallon Capital Partners, L.P. 9.99% +0.9% $197M $34.2M 9.97M +21% Dapice Joshua J. Mar 31, 2025
BlackRock, Inc. 7.5% $148M 7.5M BlackRock, Inc. Mar 31, 2025
ARCH Venture Fund IX, L.P. 4.6% -16.7% $90.7M 4.6M 0% Robert Nelsen Mar 31, 2025

Institutional Holders of Beam Therapeutics Inc. - COMMON STOCK (BEAM)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 107M $2.59B -$9.74M $24.27 210
2025 Q2 108M $1.84B +$102M $17.01 213
2025 Q1 101M $1.98B +$387M $19.53 234
2024 Q4 81.4M $2.02B +$53.4M $24.80 228
2024 Q3 78.9M $1.93B +$31.9M $24.50 217
2024 Q2 77.5M $1.82B +$145M $23.43 210
2024 Q1 70M $2.31B +$41.6M $33.04 218
2023 Q4 68.9M $1.88B +$54.7M $27.22 185
2023 Q3 67.1M $1.61B +$62.6M $24.05 189
2023 Q2 64.2M $2.05B +$124M $31.93 190
2023 Q1 60.3M $1.85B +$135M $30.62 203
2022 Q4 55.8M $2.18B +$42.4M $39.11 203
2022 Q3 54.5M $2.6B -$7.41M $47.64 213
2022 Q2 54.7M $2.09B +$193M $38.71 188
2022 Q1 49.2M $2.82B +$202M $57.30 230
2021 Q4 45.5M $3.63B -$38.9M $79.69 224
2021 Q3 45.2M $3.93B -$44.6M $87.01 221
2021 Q2 45.5M $5.85B +$343M $128.71 225
2021 Q1 43M $3.44B +$479M $80.04 204
2020 Q4 36.9M $3.01B +$631M $81.64 151
2020 Q3 29.5M $727M +$39.6M $24.62 84
2020 Q2 27.7M $776M +$34.1M $28.00 70
2020 Q1 26.9M $484M +$484M $18.00 60